{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:53:48Z","timestamp":1794002028464,"version":"4.8.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s13555-023-00989-x","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T07:01:59Z","timestamp":1690959719000},"page":"1959-1971","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Recommendations for Cost-Conscious Treatment of Basal Cell Carcinoma"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3815-3590","authenticated-orcid":false,"given":"Palak V.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N.","family":"Pixley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah S.","family":"Dibble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"issue":"10","key":"989_CR1","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","volume":"151","author":"HW Rogers","year":"2015","unstructured":"Rogers HW, Weinstock MA, Feldman SR, Coldiron BM. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. Population, 2012. JAMA Dermatol. 2015;151(10):1081\u20136.","journal-title":"JAMA Dermatol"},{"issue":"9","key":"989_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/GOX.0000000000000826","volume":"4","author":"JT Chen","year":"2016","unstructured":"Chen JT, Kempton SJ, Rao VK. The economics of skin cancer: an analysis of Medicare payment data. Plast Reconstr Surg Glob Open. 2016;4(9): e868.","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"5","key":"989_CR3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.6004\/jnccn.2016.0065","volume":"14","author":"CK Bichakjian","year":"2016","unstructured":"Bichakjian CK, Olencki T, Aasi SZ, Alam M, Andersen JS, Berg D, et al. Basal cell skin cancer, version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2016;14(5):574\u201397.","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"989_CR4","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jaad.2017.10.006","volume":"78","author":"JYS Kim","year":"2018","unstructured":"Kim JYS, Kozlow JH, Mittal B, Moyer J, Olencki T, Rodgers P, et al. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol. 2018;78(3):540\u201359.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"989_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jaad.2012.06.009","volume":"67","author":"SM Connolly","year":"2012","unstructured":"Connolly SM, Baker DR, Coldiron BM, Fazio MJ, Storrs PA, Vidimos AT, et al. AAD\/ACMS\/ASDSA\/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American academy of dermatology, American college of Mohs surgery, American Society for dermatologic surgery association, and the American society for Mohs surgery. J Am Acad Dermatol. 2012;67(4):531\u201350.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"989_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.jaad.2006.01.041","volume":"54","author":"JO Barlow","year":"2006","unstructured":"Barlow JO, Zalla MJ, Kyle A, DiCaudo DJ, Lim KK, Yiannias JA. Treatment of basal cell carcinoma with curettage alone. J Am Acad Dermatol. 2006;54(6):1039\u201345.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"989_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaad.2006.07.007","volume":"56","author":"T Rodriguez-Vigil","year":"2007","unstructured":"Rodriguez-Vigil T, V\u00e1zquez-L\u00f3pez F, Perez-Oliva N. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation. J Am Acad Dermatol. 2007;56(1):91\u20135.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"989_CR8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/S0190-9622(83)70055-1","volume":"8","author":"SJ Salasche","year":"1983","unstructured":"Salasche SJ. Curettage and electrodesiccation in the treatment of midfacial basal cell epithelioma. J Am Acad Dermatol. 1983;8(4):496\u2013503.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"989_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0733-8635(02)00022-0","volume":"20","author":"G Goldman","year":"2002","unstructured":"Goldman G. The current status of curettage and electrodesiccation. Dermatol Clin. 2002;20(3):569\u201378.","journal-title":"Dermatol Clin"},{"issue":"5","key":"989_CR10","first-page":"579","volume":"33","author":"DI Kuijpers","year":"2007","unstructured":"Kuijpers DI, Thissen MR, Berretty PJ, Ideler FH, Nelemans PJ, Neumann MH. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma. Dermatol Surg. 2007;33(5):579\u201387.","journal-title":"Dermatol Surg"},{"issue":"5","key":"989_CR11","first-page":"547","volume":"18","author":"N Basset-Seguin","year":"2008","unstructured":"Basset-Seguin N, Ibbotson SH, Emtestam L, Tarstedt M, Morton C, Maroti M, et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5-year randomized trial. Eur J Dermatol. 2008;18(5):547\u201353.","journal-title":"Eur J Dermatol"},{"issue":"10","key":"989_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1524-4725.1996.tb00588.x","volume":"22","author":"E Mallon","year":"1996","unstructured":"Mallon E, Dawber R. Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-thaw cycle schedules. Dermatol Surg. 1996;22(10):854\u20138.","journal-title":"Dermatol Surg"},{"issue":"1","key":"989_CR13","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jaad.2008.07.047","volume":"61","author":"HW Rogers","year":"2009","unstructured":"Rogers HW, Coldiron BM. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. J Am Acad Dermatol. 2009;61(1):96\u2013103.","journal-title":"J Am Acad Dermatol"},{"key":"989_CR14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1142\/9789814329668_0044","volume-title":"Modern cryosurgery for cancer","author":"D Buckley","year":"2012","unstructured":"Buckley D. Cryosurgery for non-melanoma skin cancer. In: Xu K, Korpan NN, Niu L, editors. Modern cryosurgery for cancer. Singapore: World Scientific; 2012. p. 865\u201392."},{"issue":"6","key":"989_CR15","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/sj.jid.5700740","volume":"127","author":"MM Chren","year":"2007","unstructured":"Chren MM, Sahay AP, Bertenthal DS, Sen S, Landefeld CS. Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol. 2007;127(6):1351\u20137.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"989_CR16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1046\/j.1524-4725.2000.ds00064.x","volume":"26","author":"MR Thissen","year":"2000","unstructured":"Thissen MR, Nieman FH, Ideler AH, Berretty PJ, Neumann HA. Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg. 2000;26(8):759\u201364.","journal-title":"Dermatol Surg"},{"issue":"9447","key":"989_CR17","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/S0140-6736(04)17399-6","volume":"364","author":"NW Smeets","year":"2004","unstructured":"Smeets NW, Krekels GA, Ostertag JU, Essers BA, Dirksen CD, Nieman FH, et al. Surgical excision vs Mohs\u2019 micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet. 2004;364(9447):1766\u201372.","journal-title":"Lancet"},{"issue":"1","key":"989_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.fsc.2018.08.002","volume":"27","author":"E Wong","year":"2019","unstructured":"Wong E, Axibal E, Brown M. Mohs micrographic surgery. Facial Plast Surg Clin North Am. 2019;27(1):15\u201334.","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"3","key":"989_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1524-4725.1989.tb03166.x","volume":"15","author":"DE Rowe","year":"1989","unstructured":"Rowe DE, Carroll RJ, Day CL. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol. 1989;15(3):315\u201328.","journal-title":"J Dermatol Surg Oncol"},{"issue":"6","key":"989_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/00325481.1995.11946085","volume":"98","author":"MA Kibarian","year":"1995","unstructured":"Kibarian MA, Hruza GJ. Nonmelanoma skin cancer. Risks, treatment options, and tips on prevention. Postgrad Med. 1995;98(6):39\u201340.","journal-title":"Postgrad Med"},{"issue":"17","key":"989_CR21","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1016\/j.ejca.2014.08.018","volume":"50","author":"E van Loo","year":"2014","unstructured":"van Loo E, Mosterd K, Krekels GA, Roozeboom MH, Ostertag JU, Dirksen CD, et al. Surgical excision versus Mohs\u2019 micrographic surgery for basal cell carcinoma of the face: a randomised clinical trial with 10-year follow-up. Eur J Cancer. 2014;50(17):3011\u201320.","journal-title":"Eur J Cancer"},{"issue":"8","key":"989_CR22","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/jamadermatol.2019.1259","volume":"155","author":"JG Albertini","year":"2019","unstructured":"Albertini JG, Wang P, Fahim C, Hutfless S, Stasko T, Vidimos AT, et al. Evaluation of a peer-to-peer data transparency intervention for Mohs micrographic surgery overuse. JAMA Dermatol. 2019;155(8):906\u201313.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"989_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5826\/dpc.0902a01","volume":"9","author":"J Paoli","year":"2019","unstructured":"Paoli J, Gyllencreutz JD, Fougelberg J, Backman EJ, Modin M, Polesie S, et al. Nonsurgical options for the treatment of basal cell carcinoma. Dermatol Pract Concept. 2019;9(2):75\u201381.","journal-title":"Dermatol Pract Concept"},{"issue":"5","key":"989_CR24","first-page":"525","volume":"12","author":"N Botto","year":"2013","unstructured":"Botto N, Rogers G. Nontraditional management of basal cell carcinoma. J Drugs Dermatol. 2013;12(5):525\u201332.","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"989_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1001\/archderm.143.2.266","volume":"143","author":"D Vidal","year":"2007","unstructured":"Vidal D, Mat\u00edas-Guiu X, Alomar A. Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up. Arch Dermatol. 2007;143(2):266\u20138.","journal-title":"Arch Dermatol"},{"key":"989_CR26","first-page":"1773","volume-title":"Dermatology","author":"HP Soyer","year":"2012","unstructured":"Soyer HP, Rigel DS, Wurm EMT. Actinic keratosis, basal cell carcinoma and squamous cell carcinoma. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology, vol. 2. 3rd ed. New York: Elsevier Saunders; 2012. p. 1773\u201394.","edition":"3"},{"issue":"6","key":"989_CR27","first-page":"677","volume":"18","author":"H Gollnick","year":"2008","unstructured":"Gollnick H, Barona CG, Frank RG, Ruzicka T, Megahed M, Maus J, et al. Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe. Eur J Dermatol. 2008;18(6):677\u201382.","journal-title":"Eur J Dermatol"},{"issue":"6","key":"989_CR28","first-page":"318","volume":"85","author":"C Quirk","year":"2010","unstructured":"Quirk C, Gebauer K, De\u2019Ambrosis B, Slade HB, Meng TC. Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study. Cutis. 2010;85(6):318\u201324.","journal-title":"Cutis"},{"key":"989_CR29","unstructured":"GoodRx. Imiquimod [Internet]. GoodRx. [cited 2023 March 1]. Available from: https:\/\/www.goodrx.com\/imiquimod?c=homepage-lander-sem-7&optly_audience=%7Bgeoiplogo%7D&utm_campaign=127243741&utm_content=7699746781&utm_source=google&utm_medium=cpc&utm_term=kwd-104732989523&gclid=CjwKCAiAmuKbBhA2EiwAxQnt77QfBkoqXDpZl1yBYDaFyAZLLjzbq8u"},{"key":"#cr-split#-989_CR30.1","unstructured":"Drugs.com. Efudex prescribing information. Drugs.com [updated 2021 May 1"},{"key":"#cr-split#-989_CR30.2","unstructured":"cited 2023 March 1]. Available from: https:\/\/www.drugs.com\/pro\/efudex.html"},{"issue":"4","key":"989_CR31","first-page":"433","volume":"33","author":"K Gross","year":"2007","unstructured":"Gross K, Kircik L, Kricorian G. 5% 5-Fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction. Dermatol Surg. 2007;33(4):433\u20139.","journal-title":"Dermatol Surg"},{"issue":"12","key":"989_CR32","first-page":"1369","volume":"12","author":"G Goldenberg","year":"2013","unstructured":"Goldenberg G, Hamid O. Nonsurgical treatment options for basal cell carcinoma \u2014 focus on advanced disease. J Drugs Dermatol. 2013;12(12):1369\u201378.","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"989_CR33","doi-asserted-by":"publisher","first-page":"456","DOI":"10.7326\/M18-0678","volume":"169","author":"AM Drucker","year":"2018","unstructured":"Drucker AM, Adam GP, Rofeberg V, Gazula A, Smith B, Moustafa F, et al. Treatments of primary basal cell carcinoma of the skin: a systematic review and network meta-analysis. Ann Intern Med. 2018;169(7):456\u201366.","journal-title":"Ann Intern Med"},{"key":"989_CR34","unstructured":"GoodRx. Fluorouracil [Internet]. GoodRx. [cited 2023 March 1]. Available from: https:\/\/www.goodrx.com\/fluorouracil"},{"issue":"5","key":"989_CR35","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/jdv.12150","volume":"28","author":"N Basset-Seguin","year":"2014","unstructured":"Basset-Seguin N, Bissonnette R, Girard C, Haedersdal M, Lear JT, Paul C, et al. Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy. J Eur Acad Dermatol Venereol. 2014;28(5):626\u201332.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"989_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jaad.2006.06.006","volume":"56","author":"LR Braathen","year":"2007","unstructured":"Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International society for photodynamic therapy in dermatology, 2005. J Am Acad Dermatol. 2007;56(1):125\u201343.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"989_CR37","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1365-2133.2008.08882.x","volume":"159","author":"CA Morton","year":"2008","unstructured":"Morton CA, McKenna KE, Rhodes LE, Group BAoDTGaASatBP. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008;159(6):1245\u201366.","journal-title":"Br J Dermatol"},{"issue":"4","key":"989_CR38","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/j.1365-2133.2006.07483.x","volume":"155","author":"K Caekelbergh","year":"2006","unstructured":"Caekelbergh K, Annemans L, Lambert J, Roelandts R. Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma. Br J Dermatol. 2006;155(4):784\u201390.","journal-title":"Br J Dermatol"},{"issue":"11","key":"989_CR39","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1365-4632.2008.04022.x","volume":"48","author":"P Foley","year":"2009","unstructured":"Foley P, Freeman M, Menter A, Siller G, El-Azhary RA, Gebauer K, et al. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. Int J Dermatol. 2009;48(11):1236\u201345.","journal-title":"Int J Dermatol"},{"issue":"Suppl 2","key":"989_CR40","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1038\/modpathol.3800512","volume":"19","author":"AN Crowson","year":"2006","unstructured":"Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol. 2006;19(Suppl 2):S127\u201347.","journal-title":"Mod Pathol"},{"issue":"4","key":"989_CR41","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1365-2133.2012.11061.x","volume":"167","author":"MH Roozeboom","year":"2012","unstructured":"Roozeboom MH, Arits AH, Nelemans PJ, Kelleners-Smeets NW. Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. Br J Dermatol. 2012;167(4):733\u201356.","journal-title":"Br J Dermatol"},{"issue":"22","key":"989_CR42","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.3390\/molecules25225398","volume":"25","author":"NJ Collier","year":"2020","unstructured":"Collier NJ, Rhodes LE. Photodynamic therapy for basal cell carcinoma: the clinical context for future research priorities. Molecules. 2020;25(22):5398.","journal-title":"Molecules"},{"issue":"12","key":"989_CR43","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1111\/j.1468-3083.2010.03664.x","volume":"24","author":"M Aguilar","year":"2010","unstructured":"Aguilar M, de Troya M, Martin L, Ben\u00edtez N, Gonz\u00e1lez M. A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen\u2019s disease of the lower extremities. J Eur Acad Dermatol Venereol. 2010;24(12):1431\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"989_CR44","unstructured":"GoodRx. Photoenhancers [Internet]. GoodRx. [cited 2023 March 1]. Available from: https:\/\/www.goodrx.com\/classes\/photoenhancers"},{"issue":"1","key":"989_CR45","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/bjc.1997.343","volume":"76","author":"MF Avril","year":"1997","unstructured":"Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard P, Benhamou E, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer. 1997;76(1):100\u20136.","journal-title":"Br J Cancer"},{"key":"989_CR46","first-page":"CD003412","volume":"1","author":"FJ Bath-Hextall","year":"2007","unstructured":"Bath-Hextall FJ, Perkins W, Bong J, Williams HC. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev. 2007;1:CD003412.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"989_CR47","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1001\/archderm.135.10.1177","volume":"135","author":"MR Thissen","year":"1999","unstructured":"Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol. 1999;135(10):1177\u201383.","journal-title":"Arch Dermatol"},{"issue":"7","key":"989_CR48","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1524-4725.1992.tb03508.x","volume":"18","author":"MK Silverman","year":"1992","unstructured":"Silverman MK, Kopf AW, Gladstein AH, Bart RS, Grin CM, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol. 1992;18(7):549\u201354.","journal-title":"J Dermatol Surg Oncol"},{"issue":"2","key":"989_CR49","doi-asserted-by":"publisher","first-page":"e326","DOI":"10.3747\/co.21.1727","volume":"21","author":"L Khan","year":"2014","unstructured":"Khan L, Breen D, Zhang L, Balogh J, Czarnota G, Lee J, et al. Predictors of recurrence after radiotherapy for non-melanoma skin cancer. Curr Oncol. 2014;21(2):e326\u20139.","journal-title":"Curr Oncol"},{"issue":"8","key":"989_CR50","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/ncponc0883","volume":"4","author":"JA Neville","year":"2007","unstructured":"Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol. 2007;4(8):462\u20139.","journal-title":"Nat Clin Pract Oncol"},{"issue":"5","key":"989_CR51","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1365-4632.2006.02673.x","volume":"45","author":"RI Ceilley","year":"2006","unstructured":"Ceilley RI, Del Rosso JQ. Current modalities and new advances in the treatment of basal cell carcinoma. Int J Dermatol. 2006;45(5):489\u201398.","journal-title":"Int J Dermatol"},{"issue":"2","key":"989_CR52","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2010.03.027","volume":"65","author":"M Alam","year":"2011","unstructured":"Alam M, Nanda S, Mittal BB, Kim NA, Yoo S. The use of brachytherapy in the treatment of nonmelanoma skin cancer: a review. J Am Acad Dermatol. 2011;65(2):377\u201388.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"989_CR53","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1097\/00006534-200006000-00039","volume":"105","author":"JY Petit","year":"2000","unstructured":"Petit JY, Avril MF, Margulis A, Chassagne D, Gerbaulet A, Duvillard P, et al. Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg. 2000;105(7):2544\u201351.","journal-title":"Plast Reconstr Surg"},{"issue":"8 Pt 1","key":"989_CR54","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1097\/00042728-200508000-00015","volume":"31","author":"WL Fangman","year":"2005","unstructured":"Fangman WL, Cook JL. Postradiation sarcoma: case report and review of the potential complications of therapeutic ionizing radiation. Dermatol Surg. 2005;31(8 Pt 1):966\u201372.","journal-title":"Dermatol Surg"},{"issue":"8","key":"989_CR55","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/archderm.136.8.1007","volume":"136","author":"MD Lichter","year":"2000","unstructured":"Lichter MD, Karagas MR, Mott LA, Spencer SK, Stukel TA, Greenberg ER. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire skin cancer study group. Arch Dermatol. 2000;136(8):1007\u201311.","journal-title":"Arch Dermatol"},{"issue":"3","key":"989_CR56","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1016\/j.jaad.2017.01.062","volume":"77","author":"CM Wolfe","year":"2017","unstructured":"Wolfe CM, Cognetta AB. Radiation therapy for nonmelanoma skin cancer, a cost comparison: 2016 coding changes to radiation therapy. J Am Acad Dermatol. 2017;77(3):e79\u201380.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"989_CR57","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0190-9622(84)80334-5","volume":"10","author":"H Von Domarus","year":"1984","unstructured":"Von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol. 1984;10(6):1043\u201360.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"989_CR58","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3109\/02841869609083998","volume":"35","author":"K Moeholt","year":"1996","unstructured":"Moeholt K, Aagaard H, Pfeiffer P, Hansen O. Platinum-based cytotoxic therapy in basal cell carcinoma\u2013a review of the literature. Acta Oncol. 1996;35(6):677\u201382.","journal-title":"Acta Oncol"},{"issue":"7","key":"989_CR59","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1001\/jamadermatol.2016.0780","volume":"152","author":"AA Jacobsen","year":"2016","unstructured":"Jacobsen AA, Aldahan AS, Hughes OB, Shah VV, Strasswimmer J. Hedgehog pathway inhibitor therapy for locally advanced and metastatic basal cell carcinoma: a systematic review and pooled analysis of interventional studies. JAMA Dermatol. 2016;152(7):816\u201324.","journal-title":"JAMA Dermatol"},{"issue":"6","key":"989_CR60","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S1470-2045(15)70100-2","volume":"16","author":"MR Migden","year":"2015","unstructured":"Migden MR, Guminski A, Gutzmer R, Dirix L, Lewis KD, Combemale P, et al. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol. 2015;16(6):716\u201328.","journal-title":"Lancet Oncol"},{"key":"989_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100844","volume":"35","author":"N Bertrand","year":"2021","unstructured":"Bertrand N, Guerreschi P, Basset-Seguin N, Saiag P, Dupuy A, Dalac-Rat S, et al. Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: first results of a multicenter, open-label, phase 2 trial (VISMONEO study): neoadjuvant vismodegib in locally advanced basal cell carcinoma. EClinicalMedicine. 2021;35: 100844.","journal-title":"EClinicalMedicine"},{"issue":"5","key":"989_CR62","first-page":"322","volume":"41","author":"T Kish","year":"2016","unstructured":"Kish T, Corry L. Sonidegib (Odomzo) for the systemic treatment of adults with recurrent, locally advanced basal cell skin cancer. P T. 2016;41(5):322\u20135.","journal-title":"P T"},{"issue":"6","key":"989_CR63","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ctrv.2010.12.002","volume":"37","author":"AK Ganti","year":"2011","unstructured":"Ganti AK, Kessinger A. Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer. Cancer Treat Rev. 2011;37(6):440\u20133.","journal-title":"Cancer Treat Rev"},{"key":"989_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102925","volume":"88","author":"S Ghosh","year":"2019","unstructured":"Ghosh S. Cisplatin: the first metal based anticancer drug. Bioorg Chem. 2019;88: 102925.","journal-title":"Bioorg Chem"},{"issue":"1","key":"989_CR65","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ygyno.2014.01.042","volume":"133","author":"D Lorusso","year":"2014","unstructured":"Lorusso D, Petrelli F, Coinu A, Raspagliesi F, Barni S. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecol Oncol. 2014;133(1):117\u201323.","journal-title":"Gynecol Oncol"},{"key":"#cr-split#-989_CR66.1","unstructured":"U.S. Food & drug administration. FDA approves cemiplimab-rwlc for locally advanced and metastatic basal cell carcinoma [Internet]. [updated 2021 February 1"},{"key":"#cr-split#-989_CR66.2","unstructured":"cited 2023 March 1]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-cemiplimab-rwlc-locally-advanced-and-metastatic-basal-cell-carcinoma"},{"issue":"11","key":"989_CR67","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11912-021-01120-z","volume":"23","author":"SZ Shalhout","year":"2021","unstructured":"Shalhout SZ, Emerick KS, Kaufman HL, Miller DM. Immunotherapy for non-melanoma skin cancer. Curr Oncol Rep. 2021;23(11):125.","journal-title":"Curr Oncol Rep"},{"key":"989_CR68","unstructured":"Libtayo. Libtayo cemiplimab-rwlc [Internet]. Long-term follow up data for Libtayo. [cited 2023 March 1]. Available from: https:\/\/www.libtayohcp.com\/bcc\/efficacy\/response-duration"},{"key":"989_CR69","unstructured":"Drugs.com. Libtayo prices, coupons and patient assistance programs [Internet]. [cited 2023 March 1]. Available from: https:\/\/www.drugs.com\/price-guide\/libtayo#:~:text=The%20cost%20for%20Libtayo%20intravenous,on%20the%20pharmacy%20you%20visit"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00989-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-023-00989-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00989-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T20:14:13Z","timestamp":1692648853000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-023-00989-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["989"],"URL":"https:\/\/doi.org\/10.1007\/s13555-023-00989-x","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]},"assertion":[{"value":"20 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}